BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 12617574)

  • 1. Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.
    Masur H; Kaplan JE; Holmes KK; ;
    Ann Intern Med; 2002 Sep; 137(5 Pt 2):435-78. PubMed ID: 12617574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.
    Kaplan JE; Masur H; Holmes KK; ;
    MMWR Recomm Rep; 2002 Jun; 51(RR-8):1-52. PubMed ID: 12081007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA).
    Infect Dis Obstet Gynecol; 2000; 8(1):5-74. PubMed ID: 10741830
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
    Mofenson LM; Brady MT; Danner SP; Dominguez KL; Hazra R; Handelsman E; Havens P; Nesheim S; Read JS; Serchuck L; Van Dyke R; ; ; ; ;
    MMWR Recomm Rep; 2009 Sep; 58(RR-11):1-166. PubMed ID: 19730409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group. US Public Health Services/Infectious Diseases Society of America.
    Clin Infect Dis; 1997 Oct; 25 Suppl 3():S313-35. PubMed ID: 9356832
    [No Abstract]   [Full Text] [Related]  

  • 6. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America.
    Mofenson LM; Oleske J; Serchuck L; Van Dyke R; Wilfert C; ; ;
    MMWR Recomm Rep; 2004 Dec; 53(RR-14):1-92. PubMed ID: 15577752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
    Jones JL; Hanson DL; Dworkin MS; Alderton DL; Fleming PL; Kaplan JE; Ward J
    MMWR CDC Surveill Summ; 1999 Apr; 48(2):1-22. PubMed ID: 12412613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.
    Kaplan JE; Benson C; Holmes KK; Brooks JT; Pau A; Masur H; ; ;
    MMWR Recomm Rep; 2009 Apr; 58(RR-4):1-207; quiz CE1-4. PubMed ID: 19357635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.
    Clin Infect Dis; 2000 Apr; 30 Suppl 1():S29-65. PubMed ID: 10770913
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention and treatment of common HIV-associated opportunistic complications.
    Carmichael C
    Prim Care; 1997 Sep; 24(3):561-74. PubMed ID: 9271692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world.
    Kaplan JE; Hu DJ; Holmes KK; Jaffe HW; Masur H; De Cock KM
    Am J Trop Med Hyg; 1996 Jul; 55(1):1-11. PubMed ID: 8702012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy.
    Dankner WM; Lindsey JC; Levin MJ;
    Pediatr Infect Dis J; 2001 Jan; 20(1):40-8. PubMed ID: 11176565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis against opportunistic infections in patients infected with the human immunodeficiency virus.
    Cheever LW; Chaisson RE; Gallant JE
    West J Med; 1996; 165(1-2):67-73. PubMed ID: 8855697
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylaxis of opportunistic infections in HIV/AIDS.
    Goldschmidt RH
    Am Fam Physician; 1997 Sep; 56(4):1039-40. PubMed ID: 9310055
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on opportunistic infections.
    Proj Inf Perspect; 1997 Nov; (23):16-7. PubMed ID: 11365373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prophylaxis of opportunistic infections in HIV-infected patients].
    Mayuad C
    Rev Pneumol Clin; 1993; 49(2):77-86. PubMed ID: 8272745
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of prophylaxis on the clinical manifestations of AIDS-related opportunistic infections.
    Sepkowitz KA
    Clin Infect Dis; 1998 Apr; 26(4):806-10. PubMed ID: 9564456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunistic infections: down but not out.
    Bishai WR; Chaisson RE
    Hopkins HIV Rep; 1999 Mar; 11(2):2, 7, 12. PubMed ID: 11366247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opportunistic infections: stemming the tide.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1997 Apr; 3(4):42-7. PubMed ID: 11364202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latest opportunistic infection prevention guidelines.
    D'Amico R
    Posit Aware; 1998; 9(1):43-4. PubMed ID: 11365000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.